I have reported on health and public policy issues regarding HIV/AIDS, hepatitis, harm reduction, and opioid addiction for a variety of publications, including THEBODYPRO, A&U, ATTN, and UNDARK.
New drug combo offers hope for meth use disorder. From TheBodyPro.
Courthouse interpreters say they lack COVID protections at work. From Capital and Main.
New law aims to expand access to HIV prevention. But will it? From Capital and Main.
How a midwestern HIV clinic rapidly adjusted to COVID-19. From TheBodyPro.
Where does science stand on COVID-19 outcomes for people with HIV? From TheBodyPro.
Covid 19 contact tracing could also help end HIV. From TheBodyPro.
Las Vegas gets syringe vending machines. From ATTN:.
Cincinnati Exchange Project offers needles and hope for harm reduction. From A&U.
Detention facilities can be hazardous to health. From ATTN:.
For PrEP 1-2-2 dosing, information is often bottom-up. From The Body.
Holistic care plays dividends in managing HIV, study finds. From TheBodyPro.
Coronavirus elevates Telehealth for PrEP and HIV care. From TheBodyPro.
Four digital platforms that could increase your patients’ PrEP adherence. From TheBodyPro.
Mind the gaps. New federal program aims to cover more hep C patients. From A&U, December, 2015.
Red state blues. Activists demand needle exchange programs to combat hepatitis crisis in rural America. From A&U, July, 2015.
PREP school. Finding doctors who understand Truvada takes work. From A&U.
What’s the matter with Indiana? The IV drug crisis leads to a spike in HIV and HCV in the heartland. From A&U.
Condoms and corrections. California’s controversial new law to provide safer-sex tools to prisoners. From A&U.
Blood simple. Facing pressure, the FDA changes its blood ban policy… but just a little. From A&U.
The price of zero. Drug policies in former Soviet republics like Georgia are spiking HIV and HCV rates. A&U.